Advances in developing novel therapeutic strategies for Alzheimer’s disease

Abstract Alzheimer’s Disease (AD), the most prevalent neurodegenerative disease of aging, affects one in eight older Americans. Nearly all drug treatments tested for AD today have failed to show any efficacy. There is a great need for therapies to prevent and/or slow the progression of AD. The major...

Full description

Bibliographic Details
Main Authors: Jiqing Cao, Jianwei Hou, Jing Ping, Dongming Cai
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Molecular Neurodegeneration
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13024-018-0299-8

Similar Items